POLD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.983800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.626800E-01
Normal-vs-Stage2
6.379400E-01
Normal-vs-Stage3
4.556400E-01
Normal-vs-Stage4
3.844400E-01
Stage1-vs-Stage2
7.846400E-01
Stage1-vs-Stage3
3.954400E-01
Stage1-vs-Stage4
6.580800E-01
Stage2-vs-Stage3
2.073600E-01
Stage2-vs-Stage4
1.593230E-01
Stage3-vs-Stage4
2.013200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.128000E-01
Normal-vs-AfricanAmerican
5.885200E-01
Normal-vs-Asian
7.116000E-01
Caucasian-vs-AfricanAmerican
7.820200E-01
Caucasian-vs-Asian
9.360000E-01
AfricanAmerican-vs-Asian
8.645800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.584000E-01
Normal-vs-Female
6.524200E-01
Male-vs-Female
2.975200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.839010E-01
Normal-vs-Age(41-60Yrs)
5.379000E-01
Normal-vs-Age(61-80Yrs)
7.296200E-01
Normal-vs-Age(81-100Yrs)
8.222600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.811800E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.661800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.953400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.284000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.956400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.858800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.568400E-01
Normal-vs-Daily Drinker
8.928200E-01
Normal-vs-Weekly Drinker
8.008000E-01
Normal-vs-Occasional Drinker
5.243000E-01
Normal-vs-Social Drinker
5.150200E-01
Non Drinker-vs-Daily Drinker
5.097800E-01
Non Drinker-vs-Weekly Drinker
7.698600E-01
Non Drinker-vs-Occasional Drinker
2.365200E-01
Non Drinker-vs-Social Drinker
3.260800E-01
Daily Drinker-vs-Weekly Drinker
5.063200E-01
Daily Drinker-vs-Occasional Drinker
1.105450E-01
Daily Drinker-vs-Social Drinker
1.406820E-01
Weekly Drinker-vs-Occasional Drinker
6.072200E-01
Weekly Drinker-vs-Social Drinker
7.176400E-01
Occasional Drinker-vs-Social Drinker
8.429200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.929800E-01
Normal-vs-Grade 2
2.419000E-01
Normal-vs-Grade 3
3.192800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.102900E-03
Grade 1-vs-Grade 3
1.324270E-03
Grade 1-vs-Grade 4
8.929800E-01
Grade 2-vs-Grade 3
3.116600E-01
Grade 2-vs-Grade 4
2.419000E-01
Grade 3-vs-Grade 4
3.192800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.984400E-01
Normal-vs-NonDiabetic
7.416000E-01
Diabetic-vs-NonDiabetic
6.851000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.310800E-01
Normal-vs-NoPancreatitis
8.140000E-01
Pancreatitis-vs-NoPancreatitis
3.814200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.279000E-01
Normal-vs-N1
6.459200E-01
N0-vs-N1
6.834200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.239800E-01
Normal-vs-TP53-NonMutant
6.186800E-01
TP53-Mutant-vs-TP53-NonMutant
8.742100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
